| Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds RD Hume, S Pensa, EJ Brown, PA Kreuzaler, J Hitchcock, A Husmann, ... Scientific reports 8 (1), 12658, 2018 | 34 | 2018 |
| Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modeling P Kreuzaler, MA Clarke, EJ Brown, CH Wilson, RM Kortlever, N Piterman, ... Proceedings of the National Academy of Sciences 116 (44), 22399-22408, 2019 | 18 | 2019 |
| In vitro human haematopoietic stem cell expansion and differentiation YK Bozhilov, I Hsu, EJ Brown, AC Wilkinson Cells 12 (6), 896, 2023 | 14 | 2023 |
| Fostering open collaboration in drug development for paediatric brain tumours JF Wong, EJ Brown, E Williams, AN Bullock Biochemical Society Transactions 47 (5), 1471-1479, 2019 | 5 | 2019 |
| PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo EJ Brown, L Balaguer-Lluna, AP Cribbs, M Philpott, L Campo, M Browne, ... Scientific Reports 14 (1), 328, 2024 | 2 | 2024 |
| 3032–DEVELOPING A TRACTABLE EX VIVO MODEL OF HUMAN HAEMATOPOIESIS E Brown, Y Bozhilov, I Hsu, A Wilkinson Experimental Hematology 137, 104354, 2024 | | 2024 |
| 3030–OPTIMISING POLYMER-BASED EX VIVO HUMAN HAEMATOPOIETIC STEM CELL EXPANSION CULTURES Y Bozhilov, E Brown, I Hsu, S Yamazaki, A Wilkinson Experimental Hematology 137, 104352, 2024 | | 2024 |
| PRMT5 inhibition reduces viability and stemness of pediatric high grade glioma EJ Brown, L Balaguer-Lluna, A Cribbs, M Philpott, ÁM Carcaboso, ... Cancer Research 81 (13_Supplement), 3025-3025, 2021 | | 2021 |
| Therapeutic targeting of PRMT5 and mutant ACVR1 in paediatric glioma EJ Brown University of Oxford, 2021 | | 2021 |
